Research Brief
Storing Nad Plus: Best Practices
26 Citacoes PubMedRevisado por EspecialistasCertificado GMPUltima Revisao: julho de 2026
Condições Recomendadas de Armazenamento Laboratorial
Liofilizado Powder: Store at −20°C for estabilidade a longo prazo. White to slightly yellow crystalline powder. Proteja da luz e da umidade in dark, airtight containers.
Reconstituted Solution: NAD+ in water is relatively estavel at 4°C por até 30 days. NMN estavel in drinking water for 7–10 days at room temperature.
Forms Available: Liofilizado powder, oral capsules/sublingual tablets (NMN, NR), injectable sterile solutions (SC/IM/IV), intranasal sprays, liposomal formulations.
Salt Forms: NR often stabilized as Nicotinamide Riboside Chloride (Niagen®).
Handling: Práticas laboratoriais padrão safety precautions (gloves, goggles). No CYP450 metabolismo for direto(a) NAD+.
Referencias
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolismo e seu(sua) roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021;22(2):119-141.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism. 2018;27(3):529-547.
- Verdin E. NAD+ in aging, metabolismo, and neurodegeneration. Science. 2015;350(6265):1208-1213.
- Christen S, Redeuil K, Goulet L, et al. The differential impact of three diferente NAD+ boosters on circulatory NAD and microbial metabolismo in humans. Nature Metabolism. 2025 Jan 15 [Epub].
- Trammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is unicamente and orally bioavailable in mice and humans. Nature Communications. 2016;7(1):12948.
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends in Cell Biology. 2014;24(8):464-471.
- Essuman K, Summers DW, Sasaki Y, Mao X, DiAntonio A, Milbrandt J. The SARM1 Toll/interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity que promove pathological axonal degeneration. Neuron. 2017;93(6):1334-1343.e5.
- Tarragó MG, Chini CCS, Kanamori KS, et al. A potente and specific CD38 inhibitor melhora age-related metabolic dysfunction by reversing tissue NAD+ decline. Cell Metabolism. 2018;27(5):1081-1095.e10.
- Zhang H, Ryu D, Wu Y, et al. NAD+ repletion melhora mitochondrial and stem cell function and aprimora life span in mice. Science. 2016;352(6292):1436-1443.
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide aumenta muscle sensibilidade a insulina in prediabetic women. Science. 2021;372(6547):1224-1229.
- Cantó C, Houtkooper RH, Pirinen E, et al. The NAD+ precursor nicotinamide riboside aprimora oxidative metabolismo and protege against high-fat diet-induziu obesidade. Cell Metabolism. 2012;15(6):838-847.
- Brakedal B, Dölle C, Riber F, et al. The NADPARK study: a randomizado phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism. 2022;34(3):396-407.e6.
- Wu J, et al. Nicotinamide riboside reduz pTau217 in older adults with mild cognitive impairment. Alzheimer's & Dementia: TRCI. 2025.
- Das A, Huang GX, Bonkowski MS, et al. Impairment of an endothelial NAD+-H₂S signaling network is a reversible cause of vascular aging. Cell. 2018;173(1):74-89.e20.
- Guan Y, Wang SR, Huang XZ, et al. Nicotinamide mononucleotide, an NAD+ precursor, rescues age-associated susceptibility to AKI in a sirtuin 1-dependent manner. Journal do(a) American Society of Nephrology. 2017;28(8):2337-2352.
- Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. Nicotinamide mononucleotide supplementation aprimora aerobic capacity in amateur runners. Journal do(a) International Society of Sports Nutrition. 2021;18(1):54.
- Mills KF, Yoshida S, Stein LR, et al. Long-term administration of nicotinamide mononucleotide mitiga age-associated physiological decline in mice. Cell Metabolism. 2016;24(6):795-806.
- Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. 2022;8(1):5.
- Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide supplementation in healthy middle-aged adults. GeroScience. 2023;45(1):29-43.
- Pencina KM, Lavu S, Dos Santos M, et al. MIB-626, an oral formulation of a microcrystalline unique polymorph of β-nicotinamide mononucleotide, aumenta circulating NMN and NAD+ in a randomizado ensaio clinico. Journal of Clinical Endocrinology & Metabolism. 2023;108(4):862-871.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is bem tolerado(a) and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9(1):1286.
- Wang DD, et al. Nicotinamide riboside in insuficiencia cardiaca with reduziu ejection fraction. JACC: Basic to Translational Science. 2022.
- de la Rubia JE, Drehmer E, Platero JL, et al. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomizado, duplo-cego, controlado por placebo human pilot study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2019;20(1-2):115-122.
- Grant R, Berg J, Mestayer R, et al. A pilot study investigating changes no(a) human plasma and urine NAD+ metabolome during a 6 hour intravenoso(a) infusion of NAD+. Frontiers in Aging Neuroscience. 2019;11:257.
- Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, um(a) principal NAD+ intermediate, treats the pathophysiology of diet- and age-induziu diabetes in mice. Cell Metabolism. 2011;14(4):528-536.
- Poljsak B, Kovač V, Špalj S, Milisav I. The central role do(a) NAD+ molecule in o desenvolvimento of aging e o(a) prevention of cronico(a) age-related diseases. International Journal of Molecular Sciences. 2023;24(3):2959.
Perguntas de Pesquisa Relacionadas
APENAS PARA USO EM PESQUISA
Este conteudo e fornecido apenas para fins educacionais e informativos. Os produtos sao fornecidos apenas para estudos in vitro e nao sao medicamentos, drogas ou suplementos. Nao aprovado pela FDA para prevenir, tratar ou curar qualquer condicao.